Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028300 · ClinicalTrials.gov registry record · NA
Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel
A NA study, sponsored by Synthes USA HQ.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01028300 is a NA study that was terminated before completion, run by Synthes USA HQ. The registered enrollment target is 4 participants.
The verdict
NCT01028300, a NA study, was terminated before completion, sponsored by Synthes USA HQ.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Degenerative disc disease (DDD) refers to a syndrome in which a degenerating disc causes chronic back pain, significantly impacting an individual's ability to function. The condition is most commonly diagnosed in the lumbosacral spinal segments L3-S1. The condition often starts with an injury to the disc space. The injury weakens the disc and creates excessive motion at the corresponding vertebral level. Over time, the segmental instability and associated neurological compromise combined with ongoing inflammatory processes that occur in and around the disc produce low back pain. The reparative processes in the disc are poor, thus the painful symptoms can become chronic. Premature degeneration at adjacent levels of the spine remains one of the more vexing problems facing spinal surgeons when advising relatively young people to consider lumbar fusion surgery. Stopping the motion changes the mechanics of the back (which is designed for motion and flexibility) and results in the transfer of the loads and stresses to the adjacent vertebral segments. It is therefore intuitive to pursue total disc replacement, which allows for the treatment of pain due to DDD while re-establishing motion and stability, load distribution, and restoring the disc height, as an alternative to spinal fusion surgery. The study hypothesis is that military personnel receiving Total Disc Replacement will return to the same level of active duty performance as at the time of their most recent successful physical readiness test.
Interventions
- DEVICE ProDisc™-L Total Disc Replacement (TDR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028300
The ClinicalTrials.gov registry entry for NCT01028300 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synthes USA HQ, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProDisc™-L Total Disc Replacement (TDR) is the first listed.
NCT01028300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028300 about?
NCT01028300 is a clinical study titled "Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel". Degenerative disc disease (DDD) refers to a syndrome in which a degenerating disc causes chronic back pain, significantly impacting an individual's ability to function. The condition is most commonly diagnosed in the lumbosacral spinal segments L3-S1. The condition often starts with an injury to the...
What is the current status of trial NCT01028300?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2010-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01028300?
The interventions under investigation include: ProDisc™-L Total Disc Replacement (TDR) (DEVICE).
Who is sponsoring clinical trial NCT01028300?
This trial is sponsored by Synthes USA HQ, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.